aspirin has been researched along with su 11248 in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Huang, J; Huang, Y; Wang, T | 1 |
| Campanella, R; Caroli, M; Cordiglieri, C; Crisà , FM; Guarnaccia, L; La Verde, N; Locatelli, M; Marfia, G; Miozzo, M; Navone, SE; Rampini, P; Riboni, L; Schisano, L | 1 |
| Aarts, MJB; Baaten, CCFMJ; Campello, E; Eble, JA; Fernández, DI; Heemskerk, JWM; Kuijpers, MJE; Peters, LJF; Simioni, P; Spiezia, L; Tullemans, BME; van der Meijden, PEJ; van der Vorst, EPC; Veninga, A | 1 |
1 review(s) available for aspirin and su 11248
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
3 other study(ies) available for aspirin and su 11248
| Article | Year |
|---|---|
Exfoliative esophagitis in a patient with metastatic renal cell carcinoma during sunitinib treatment.
Topics: Amlodipine; Antihypertensive Agents; Antineoplastic Agents; Aspirin; Carcinoma, Renal Cell; Cyclooxygenase 2 Inhibitors; Esophagitis; Humans; Hypertension; Indoles; Kidney Neoplasms; Lung Neoplasms; Male; Middle Aged; Nephrectomy; Pyrroles; Sunitinib; Tetrazoles; Valine; Valsartan | 2013 |
Aspirin Affects Tumor Angiogenesis and Sensitizes Human Glioblastoma Endothelial Cells to Temozolomide, Bevacizumab, and Sunitinib, Impairing Vascular Endothelial Growth Factor-Related Signaling.
Topics: Angiogenesis Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Immunological; Aspirin; bcl-2-Associated X Protein; Bevacizumab; Blotting, Western; Brain Neoplasms; Cell Survival; Drug Synergism; Endothelial Cells; Glioblastoma; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Mitogen-Activated Protein Kinase Kinases; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; ras Proteins; Real-Time Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Sunitinib; Temozolomide; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1; Vascular Endothelial Growth Factor Receptor-2 | 2018 |
Tyrosine Kinase Inhibitor Sunitinib Delays Platelet-Induced Coagulation: Additive Effects of Aspirin.
Topics: Aspirin; Blood Coagulation; Humans; Platelet Aggregation; Protein Kinase Inhibitors; Sunitinib; Thrombosis | 2022 |